By Cristal Cody
Eureka Springs, Ark., May 31 – Pfizer Inc. sold $5 billion of notes (A1/AA/A+) in five parts, including a tap of existing long bonds on Tuesday, according to a market source.
The company sold $1.25 billion of 1.2% two-year notes at Treasuries plus 35 basis points, on the tight side of guidance of 40 bps, plus or minus 5 bps, over Treasuries.
Pfizer priced $850 million of 1.45% three-year notes at 45 bps over Treasuries, compared to talk of Treasuries plus 50 bps, plus or minus 5 bps.
The $1.15 billion tranche of 1.95% five-year notes priced with a spread of 60 bps over Treasuries. The notes were guided at Treasuries plus 65 bps, plus or minus 5 bps.
Pfizer placed $1.25 billion of 2.75% 10-year notes at 90 bps over Treasuries, compared to guidance of 95 bps, plus or minus 5 bps, over Treasuries.
In addition, Pfizer priced a $500 million add-on to its 4.4% notes due May 15, 2044 at Treasuries plus 115 bps, on the tight side of guidance of 120 bps, plus or minus 5 bps, over Treasuries.
Pfizer originally sold the 4.4% notes due 2044 in a $500 million offering on May 12, 2014 at 95 bps over Treasuries. The total outstanding is $1 billion.
Barclays, Goldman Sachs & Co., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC were the bookrunners.
Proceeds will be used for general corporate purposes and to repay outstanding commercial paper, according to details from a 424B3 filing with the Securities and Exchange Commission.
Pfizer is a biopharmaceutical company based in New York.
| Issuer: | Pfizer Inc.
|
| Amount: | $5 billion
|
| Securities: | Senior notes
|
| Bookrunners: | Barclays, Goldman Sachs & Co., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC
|
| Pricing date: | May 31
|
| Settlement: | June 3
|
| Ratings: | Moody’s: A1
|
| S&P: AA
|
| Fitch: A+
|
| Distribution: | SEC registered
|
|
|
| Two-year notes
|
| Amount: | $1.25 billion
|
| Maturity: | June 1, 2018
|
| Coupon: | 1.2%
|
| Spread: | Treasuries plus 35 bps
|
| Price guidance: | Treasuries plus 40 bps, plus or minus 5 bps
|
|
|
| Three-year notes
|
| Amount: | $850 million
|
| Maturity: | June 3, 2019
|
| Coupon: | 1.45%
|
| Spread: | Treasuries plus 45 bps
|
| Price guidance: | Treasuries plus 50 bps, plus or minus 5 bps
|
|
|
| Five-year notes
|
| Amount: | $1.15 billion
|
| Maturity: | June 3, 2021
|
| Coupon: | 1.95%
|
| Spread: | Treasuries plus 60 bps
|
| Price guidance: | Treasuries plus 65 bps, plus or minus 5 bps
|
|
|
| 10-year notes
|
| Amount: | $1.25 billion
|
| Maturity: | June 3, 2026
|
| Coupon: | 2.75%
|
| Spread: | Treasuries plus 90 bps
|
| Price guidance: | Treasuries plus 95 bps, plus or minus 5 bps
|
|
|
| Add-on
|
| Amount: | $500 million reopening
|
| Maturity: | May 15, 2044
|
| Coupon: | 4.4%
|
| Spread: | Treasuries plus 115 bps
|
| Price guidance: | Treasuries plus 120 bps, plus or minus 5 bps
|
| Total outstanding: | $1 billion
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
